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1 This policy report is based in Epinet's WP3 case study on wearable sensors for health and self care, fitness and
well-being. The partners have shared their notes and reflections on three years of research in order to produce
a shared summary of key findings along with policy recommendations. As the rapporteur and work package
leader, I extend my gratitude for excellent scholarship, brilliant insights and good working spirit.
Objectives and aims of the case study
This document provides a set of policy recommendations, based on the findings of a three-year
long  case  study  on  wearable  sensors.  The  key  objective  was  to  assess  state-of-the-art
developments in this domain of innovation, using evaluation and analytic methods that correspond
with  the expertise  and experience available  on  our  study  team and  among our  associates  in
industry and innovation, medicine, policy, grass roots activism, STS and ELS study traditions. Our
aim is to  provide guidelines for good governance of wearable sensors, in light of their potential
roles  in  medical  settings  as  well  as  their  currency  as  consumer  electronics  for  quasi-medical
purposes.  We  provide  recommendations  for  ongoing  innovation  in  this  field,  considering  the
necessity of mutual recognition and reflexive knowledge exchange among innovators and industrial
actors, medical expertise, scholarly and technical assessments, patient organisations and grass
roots activism, policy developers and regulators.
Our policy recommendations are aimed at two rather different areas of policy development and
policy intervention. First, we present a set of  discussion points (sections 1, 2 and 3), directed at
scientific and innovation policy advisory bodies to the European Science Foundation (ESF),
the Digital Agenda, the Commission's DG Research, DG Health and other relevant directorates,
innovation and research funds/agendas/programmes in matters of health and social  care, ICT-
driven innovations in healthcare (eHealth / mHealth) and Public Health initiatives. We are directing
our recommendations here at the development of innovation policy—of navigating the future of
healthcare with the support of institutional politics and configurations that should be reconsidered
and re-evaluated more critically and more frequently than currently is the case. Secondly, we have
unravelled legal and regulatory uncertainties concerning devices and services already in use and
widely available on the market (sections 4.1, 4.2 and 4.3). We direct our recommendations here at
authorities  of  medicines  and  health  products across  Europe  and  the  associated  Health
Technology  Assessment  (HTA)  bodies, the  Commission's  DG-Connect,  the  European  Data
Protection Supervisor (EDPS) and the Article 29 Working Party, as well the individual country-
based Data Protection Authorities (DPAs).2  
Policy concerns
During the early stages of this case study, the future of care and the future of the informational
embodied person were two topical areas identified on the basis of a changing politics of care and
the influx of gadget use-data, behaviour-data, location-data and other incidental data in the mix
with data on people's physiological states and medical conditions. The responsibility for providing
care is shifting from public institutions to private enterprise, toward more personalised care, patient
choice and individuals being themselves in charge of their care needs. It follows that increased use
of wearable computing and sensor technology to support the new care practices, necessitates col-
lection, processing and dissemination of data on persons and bodies in ways that can be hard to
reconcile with directives on the protection of such data. It can also be argued that predominant vi-
sions of 'measure and monitor' to support health and self care, are reductionist in their orientation
to  care as data practice. The two topical domains have gathered more specific considerations
and policy questions which have evolved over time and eventually culminated in the  discussion
points and recommendations we present in this document.
2 Our recommendations here are considering of recent legal and regulatory developments, in particular, the General
Data Protection Regulation (GDPR) proposal. European Parliament and the Council of the European Union. (in-
progress). Regulation of the European Parliament and of the Council on the protection of individuals with regard to
the processing of personal data and on the free movement of such data.
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Summary of findings
Wearable sensors for health and self care, fitness and well-being, are gadgets on the move and
in stasis. They blur the boundaries between healthcare and the self-administration of care when
patients begin to actively self-monitor using wearables and biosensors as part of ongoing care.
They shift these boundaries when consumer electronics are marketed and put to use for medical
purposes—devices which then sit in a policy vacuum since there is no adequate legal framework
with  binding  rules  to  cover  consumer  gadgets  in  medical  settings  (Green  Paper  on  mHealth,
2014).3 Yet, the boundaries are drawn quite clearly when wearable sensors are marketed for quasi-
medical purposes, for which the HTA frameworks and the European medical devices directive do
not apply. Moreover, wearable sensors, whether or not they classify as mHealth technology, are
not indiscriminately on the move. In fact, their flexibility is confined to prescription: that of structured
activity, of locality, stasis and types of measure and monitoring built into them, including standards
on data capture and data processing.
We learn from our explorations that policy and research  programmes are promising flexible and
more personalised care, patient involvement and greater citizen responsibility in managing disease
and staying healthy. Alongside that is a very positive media environment, accommodating media
commentaries which are almost  entirely based on promotional  materials  that  endorse the new
gadgets and services. It is not clear however, how ICT-based and mobile technologies will impact
in the long run on publicly or privately provided care and public health targets. Wearable sensors fit
into  grander visions of a healthcare revolution—of an evolving ecosystem of objects, functions,
services and growing incentives to take charge of one's life. But, there is implied bias here toward
prediction and control which reduces care to control measures and over-simplifies care relations
and communication on care. We come across the notion of  empowerment, of taking charge and
being in  charge as if  citizens can be relatively  free of  ordinary  social-cultural  constraints  and
unaffected  by  the  particularities  of  the  healthcare  actually  available  to  them.  The  notion  of
empowerment  raises  a  question  of  whether  existing  digital  divides  and health  inequalities  are
exacerbated.  It  is  of  particular  curiosity as well  to discover  the disconnect  between the policy
visions of the future of healthcare for European citizens and the grass roots activities in self care
3 European Commission. (2014) Green Paper on mobile health (“mHealth”). Brussels, 10.4.2014. COM(2014) 219 
final.
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Policy-relevant considerations:
Reform in healthcare delivery across Europe comes with great emphasis on more personalised 
care, patient choice, private insurance and personal responsibility. 
Personalised care is shifting roles, relations and responsibilities in care-giving.
Mass marketing of smartphone-enabled apps and accessories are blurring the boundaries 
between healthcare, self care, fitness and well-being applications. 
New service 'hubs' for mobile data gathering and the processing of health-related and 
potentially sensitive information, are a challenge to the protection of privacy and personal data.
Key policy questions:
Are the policy goals of more personalised delivery of care realistic? Will they improve the access 
to adequate care for all or exacerbate existing health inequalities?
Are the policy goals of medical devices regulators realistic? Do they take into account the 
growing use of consumer gadgets and apps to detect and manage health-related conditions?
Are the policy goals of protecting personal data realistic? Do they take into account the 
complications introduced by incentives to share data, for example, in exchange for access to 
data processing.
such as the Quantified Self (QS) movement, hackerspaces and other initiatives that are leaning
toward the self-administration of care and a co-construction of care-relevant knowledge. Finally, as
a result  of  the  lack  of  a  regulatory  framework  for  consumer  electronics  in  use for  healthcare
purposes, we discover a whole host of issues associated with an emerging market of  health as
leisure,  whose success should be considered in  reference to  value creation  rooted in  cultural
trends and traits, not the practical improvements promised in policy documents (e.g. eHealth Action
Plan  and  the  ESF  Forward  Look  on  personalised  Medicine  for  the  European  Citizen).4 The
business models typically rely  on common denominators  to trawl for data in large numbers—to
prescribe and exploit traits and trends of behaviour on a mass-scale for commodification purposes
(see Gunnarsdóttir et al, 2015 submitted).5
We have achieved these learnings by engaging a number of disciplines that are all well equipped
to  assess  new-emerging  domains  of  innovation,  although,  their  approaches  vary  significantly:
knowledge assessment, ethics, law, socio-technical evaluation, digital culture and media studies.
We have also engaged medical expertise, policy research, regulators and self-care activists, to
gain the insights of  a much wider  network  of  professional  and other  relevant  experience with
wearable sensors. These exercises in knowledge exchange and debate form an important part of
our case study, i.e.,  to evaluate the enablers and constraints of various stakeholder views and
assessment methods, in particular, what is gained by bringing them together as we have done.6
We proceed with our policy recommendations as a series of questions to be openly considered
and debated:
• Questions  concerning  the  involvement  across  knowledge  sectors,  occupations  and
ideologies in debate and deliberation:  rethinking the policy actors and the policy
action.
• Questions relevant to policy development to-date and corresponding pressures on  the
medical  establishment:  the  need  to  consider  the  feasibility  and  viability  of
technological faiths and fixes.
• Questions concerning the disconnect between visions articulated in policy programmes
and the grass roots activism that aims at supporting the self-administration of care; also
the disconnects in use/non-use patterns of  affluent  techie consumers as opposed to
those without the means and the access.
• Questions concerning the regulatory and legal uncertainties about devices and services
already available in care markets.
4 European Commission. (2012) eHealth Action Plan 2012-2020 - Innovative healthcare for the 21st century. 
Brussels, 6-12-2012;  ESF Forward Look. (2012) personalised Medicine for the European Citizen - Towards more 
precise medicine for the diagnosis, treatment and prevention of disease (iPM). Europan Science Foundation.
5 Gunnarsdóttir, K., Breitegger, M., Dijk, N. van., Fotopoulou, A., Guimarães Pereira, Â., O'Riordan, K., 
Rommetveit, K. and Vesnic-Alujevic, L. (2015, submitted). Tracking biosensors: healthcare, wellbeing and new-
emerging markets. Draft copy of preprint is available at http://neicts.lancs.ac.uk/pdf/  Preprint-Care-Markets.pdf .
6 Other publications and conference papers under review and forthcoming are:
a) Vesnic-Alujevic, L., Breitegger, M. and Guimarães Pereira, Â. (2015, forthcoming). 'Do it yourself' 
healthcare? Quality of health and healthcare through wearable sensors. Science and Engineering Ethics;
b) Fotopoulou, A. and O'Riordan, K. (2015, submitted). Training to self-care: Fitness tracking and the 
knowledgeable consumer. European Journal of Cultural Studies;
c) Breitegger, M., Vesnic-Alujevic, L. and Guimarães Pereira, Â. (2015, submitted). Wearable Sensors - 
Assessing Knowledge of Epistemic Networks. Science and Technology Studies;
d) Gunnarsdóttir, K. and Guimarães Pereira, Â. (eds) (2015, book proposal). Making sense of wearable care. 
Markets, mediascapes and the informational person. Palgrave;
e) Guimarães Pereira, Â. and Gunnarsdóttir, K. (2015, submitted). Self-tracking and critical sense-making: an 
emerging epistemic network (conference paper). 4S Annual Conference, Denver, Colorado 11-14 November. 
Session title: Exploring self-tracking: between submission and resistance.
f) Fotopoulou, A. (in preparation). 'All these emotions, all these yearnings, all these data': big data and the 
moral economy of data sharing. Invited submission to Big Data and Society.
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Policy considerations and recommendations
The next three sections (1, 2 and 3), are directed at scientific and innovation policy advisory
bodies to the ESF, the Digital Agenda, the Commission's DG-Research,  DG-Health, and other
relevant innovation and research funds/agendas/programmes in matters of health and social care,
ICT-driven innovations in healthcare (eHealth / mHealth) and Public Health initiatives.
(1)  Rethinking the policy actors and the policy action: expertise and experience
Explanation/findings:  Navigating  the  future  of  healthcare,  patient  activism  and  the  self-
administration of care, concerns all Europeans. Care is woven into the fabric of everyday life
and everyone is at one point or other facing the consequences of change. This reminds us
that EC and EU policy-makers are not the only,  or necessarily the most important policy
actors in developing an innovation policy with claims upon the future politics of care and what
the priorities need to be to ensure sustainable quality care—what should be the institutional
(re)structuring, the technological and socio-cultural innovations, and the reimbursement and
funding schemes to provide care or to otherwise support it. 
In the case of wearable sensors as part of the eHealth and mHealth programmes, there are
questions to debate and deliberate across a wide range of expertise, professional and other
relevant  experience  to  shape  and  cultivate  an  epistemic  network.  Such  a  network  is
necessarily dynamic and fluid, an emergent network of a rather different constitution than the
narrow aggregates of policy actors who – so far – appear to have exclusive access to policy
development and decision-making procedures.
Policy considerations: In navigating the future of healthcare for European citizens, we strongly
recommend rethinking how the policy environment is shaped:
• Is the policy action mindful of the sensitive nature of future-making on behalf of European
citizens?
• Is the policy action mindful of the limits of prediction and know-how?
• Is the policy action an  exploratory action? Is  it  experimental,  a  fact finding mission
across knowledge sectors, occupations and ideologies?
• Is the policy action a work-in-progress, aiming toward discovery – on an ongoing basis –
of the kinds of things that can be imagined and stated about an innovation domain?
(2)  Policy and the medical establishment: faith and fixes
Explanation/findings: Are politics and innovation policy pulling the medical establishment on
the future of eHealth and mHealth, being pushed by it, or both? The policy literature and
funding programmes tell a mixed story which indicates to us a lack of clarity in the innovation
and policy rationale.
Policy considerations: We strongly recommend achieving clarity on the following points: 7
• Are  the  innovation  narratives  on  eHealth and  mHealth mindful  of  potential  bias  of
prediction and control, of reducing care to control?
• Are among the policy actors also those who are inclined to question faith in technological
fixes? What alternatives do their insights have to offer?
• Are the innovation narratives  over-simplifying communication and interrelations,  for
7 For individual applications aimed at elderly persons, we recommend consulting discussion points raised in: 
EFORTT. (2011) Care with technology? An ethical framework for telecare. EFORRT, Lancaster University. 
http://www.lancaster.ac.uk/efortt/ .
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example,  between  patients  and  doctors,  policy-makers  and  innovators,  and  people's
experiences of their lived bodily selves?
• Are the  innovation  narratives  reducing medical  consultation to data  collection and
information gathering, to substitute for in-depth communication that necessitates taking
into account cultural, environmental and physiological specificities of a medically-relevant
case?
• Does the emphasis on individual empowerment take adequately into account which care
provisions are actually available and the full range of personal circumstance affecting
motivations and abilities, including economic hardship or any form of exclusion from access
to high tech solutions?
(3)  Policy and grass roots action: a (dis)connection
Explanation/findings:  We  observe  a  disconnect  between  top-down  thinking  in  policy
development aiming at personalised healthcare and mHealth, and the kinds of grass-roots
developments that show what people actually do when left to their own devices, and how
lead markets take shape.8 The policy discourse takes little if any notice of self-generating
trends in managing health-related conditions with the support of devices and online services,
self-help and peer-communication portals. The industry is often well aware of such trends
and  capitalises  on  them,  but  the  institutional  structuring  for  devices  regulation  is
disconnected.
Policy considerations: We strongly recommend achieving clarity on the following points:
• Is  the  policy  discourse  on  eHealth  and  mHealth  making  irresponsible  promises of
healthcare revolutions, suggesting that electronic devices and services (including wearable
sensors) are key to improved care delivery, increased efficacy and cost savings?
• What can be done to better identify the uncertainties (social, ethical, legal, technological
and  political)  in  shifting  responsibilities  for  care into  the  hands  of  individuals
themselves?
• Are among the policy actors also those who are  knowledgeable and involved in DIY
design and development—those who observe first hand the implications for healthcare
policy?
• How can lessons from grass roots action be incorporated into the established practices,
e.g., on criteria for data protection by-design, on issues of inclusion/exclusion, and other
relevant concerns?
(4)  Regulatory and legal uncertainties
The following set of  recommendations (4.1,  4.2,  4.3)  is  presented for immediate consideration and
action in response to devices and services already in use and widely available on the market. They are
directed  at  authorities of medicines and health products across Europe and the associated
Health Technology Assessment (HTA) bodies, the Commission's DG-Connect, the EDPS and the
Article 29 Working Party, as well the country-based DPAs.
(4.1)  Devices regulation
Explanation/findings: Consumer electronics and apps are used by patients as part of ongoing
care, and consumer electronics and apps are marketed and put to use for medical purposes.
These mHealth practices both push and blur the boundaries between healthcare, patient
8 See report on expert workshop in Brussels 5 Nov 2013. http://neicts.lancs.ac.uk/  pdf/EPINET-D3.2_WP3.pdf .
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participation, and the self-administration  of  care; between consumer rights and law and the
EU  Council  Directive  concerning  medical  devices.9 The  2012  ESF  forward  look  on
personalised medicine10 recommends that healthcare professionals work with ICT experts to
define, for example, how smartphone-paired and smartphone-enabled sensors and apps can
function as decision-support tools for citizens.11 It recommends a flexible health technology
assessment (HTA) framework to support the adoption of new technologies of added value to
conventional care. But, if the new gadgets and services are not strictly classified as medical,
and  regulated  as  such,  they  effectively  sit  in  a  policy  vacuum.  There  is  no  clear  legal
framework yet, with binding rules, to ensure that developments, uptake and use are sound,
as the green paper on mHealth puts it (2014, 3.3, pp.10-11).
Recommendations:  We  strongly  recommend  deliberation  for  action  in  response  to  mHealth
developments:
• What can be done to establish an adequate legal framework, with binding rules, to cover
safety and performance requirements of quasi-medical devices?
• How  can  legal  ramifications  be  adequately  (re)drawn  between  consumer  and  medical
wearables?
• Is there need to strengthen the enforcement of EU legislation applicable to mHealth, by
competent authorities and courts; if yes, why and how?
(4.2)  Conflating legal frameworks
Explanation/findings:  The terms of use of  social networking sites (SNS)  often specify that
users grant the service provider 'perpetual,  irrevocable'  right  to 'commercially exploit  any
text, photographs or other data and information' submitted to the online service. From a legal
perspective, 'terms of use' in these environments present a strange hybrid of data protection
law and something akin to copyright law. This is also the case for SNS, processing wearable
sensor data and associated information on the individual. By framing data and information as
'user-generated content'  and defining their  use according to terms seemingly  taken from
copyright licensing, the locus of regulation and control of private and potentially sensitive
data is presented to the user under the legal regime of quasi-intellectual rights, not that of
data protection. 'User-generated content' however, is not a widely accepted legal term. It can
be said to resemble copyright to the extent that creating the content requires original input,
although, that is potentially misleading because it can be questioned whether the data exhibit
the  'certain  amount  of  creative  effort'  necessary  to  qualify  as  copyright  user-generated
content (OECD, 2007).12 It is also misleading to suggest that data protection is waived in this
way. Rights and obligations concerning personal data cannot be so freely contracted away.
For instance, consent is always revocable and never perpetual.
Recommendation: We strongly recommend clarifying the legal status of user-generated content
in  Europe,  as  well  as  the  status  of  data  protection  law  in  relation  to  the  creation,  storing,
processing and sharing of such content.13
9 Council. (1993) Council Directive 93/42/EEC of 14 June 1993 concerning medical devices. Official Journal of the 
European Communities L 169/1. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:31993L0042 . See also 
http://ec.europa.eu/consumers/consumer_rights/index_en.htm on EU consumer rights and law.
10 ESF Forward Look. (2012)  personalised Medicine for the European Citizen - Towards more precise medicine for 
the diagnosis, treatment and prevention of disease (iPM). European Science Foundation.
http://www.esf.org/uploads/media/Personalised_Medicine.pdf 
11 Recommendations 7.3, p. 50.
12 OECD. (2007) Participative Web and User-Created Content. Web 2.0, Wikis, and Social Networking. Paris: OECD.
13 We suggest here an Article 29 WP Opinion.
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(4.3)  Data protection and data protection impact assessment (DPIA)
Explanation/findings:  The  DPIA  Framework  for  Radio  Frequency  Identification  (RFID)
applications14 was established in response to the sudden ubiquity of RFID units and to the
nature of their use in data handling operations. In light of a recent surge in wearable sensors
for health, fitness and well-being purposes, and given the technical similarities between RFID
units and wearable sensors, the RFID framework can be considered a relevant basis for
DPIAs of the use and handling of wearable sensor data. Furthermore, since these devices
will process personal data 'concerning health' and 'for the provision of healthcare', a DPIA
will be mandatory under the proposed European GDPR regulation (art. 32a.2b&d GDPR).
Policy considerations: We strongly recommend achieving clarity on the following points:
• DPIAs for the handling of wearable sensor data will need to consider the limitations of risk
assessment  methods,  by  paying  attention  to  risk  framing  and  uncertainties,  public
engagement  protocol  and legal  lessons on the substance of  rights  and procedures  for
dealing with them.
• Preparing and organising DPIAs for  the handling of  wearable sensor data will  need to
consider a protocol for justifying the basis on which the considerations listed in the previous
point are taken into account: 
◦ Is the rationale for the inclusion of risk assessment methods and risk framing
mindful of user experiences, potential design complications and the risk of live
system faults, including operational/administrator errors?
◦ Is the DPIA covering and reflecting upon 'inconvenient' uncertainties?
◦ Are public engagement plans going past the survey model, considering focus
groups,  scenario  workshops,  consensus  conferences  and  science  cafés,
deliberative polls and citizen juries?
Explanation/findings:  Adequately addressing issues of data protection is a pressing matter
when  the  registration  process  onto  online  data  platforms  and  SNS  that  accommodate
wearable sensor data, is visually designed in such a way that it nudges the user to ignore
privacy policies and terms of service. The same argument applies to the visual design of the
platforms themselves. They often nudge users to make the least privacy friendly choices.
The layout of privacy policies has also been criticized for being opaque, typically using small
block text format creating impenetrable textures rather than readable text.15
Recommendations: Several paths should be explored for deliberation and action:
• Data controllers of online data platforms should be driven to take more consumer-centred
approaches.
• What  kind  of  incentives  can  be  put  into  effect  to  help  deliver  more  consumer-centred
approaches,  e.g.,  should  international  self-regulatory  codes  or  best  practices  be
considered, or a facilitation of collective action through EU redress mechanisms? 16
• Data  controllers  should  incorporate  relevant  aspects  of  the  General  Data  Protection
Regulation (when legislated), or more precisely the obligation currently in the proposal, that
data controllers should offer 'transparent and easily accessible policies'  so that the data
subjects can exercise their rights (Article 11.1 GDPR).
14 See Working group on the implementation of RFID communication. (2011). Privacy and Data Protection Impact 
Assessment Framework for RFID applications.
15 For example Hoback, C., director. (2013) Terms and Conditions May Apply. USA: Hyrax Films.
16 See Wauters, E., Lievens, E. and Valcke, P. (2014). Towards a better protection of social media users: a legal 
perspective on the terms of use of social networking sites. International Journal of Law and Information Technology 
22(3): 254-294.
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• How can the creation of general tools that enhance awareness and understanding of data
policies (like rating and labelling), be stimulated? 17
Similar  arguments  pertain  to  more  general  issues  of  data  control  and  transparency  in  the
operations and use of online data platforms and SNS:
• Data controllers should establish procedures and mechanisms for the architecture of online
data platforms and user interfaces, to enable data subjects to effectively exercise their rights
(to object, access, modify or delete their data), and be provided with information about the
nature  of  the  data  processing.  This  means  also  that  system  transparency  and  user
empowerment – as the law requires - should be designed into the architecture to afford
action,  but  that  will  also  be  an  obligation  of  the  data  controller,  i.e.,  to  practice  'data
protection by design' (Article 23.1 GDPR).
• An important objective for establishing the need for these measures should be the degree to
which they enable data subjects to effectively understand their  own informational actions
online and to exert control over their informational citizenship and person-hood.
• A further consideration is whether the 'by design' framework will have to be expanded upon
to cover issues like non-discrimination.
17 Ibid.
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